ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

On October 26, 2009, Interleukin Genetics, Inc. (the "Company") entered into a Merchant Network and Channel Partner Agreement (the "Agreement") with Amway Corp. d/b/a Amway Global ("Amway Global"), a subsidiary of Alticor Inc. Pursuant to this Agreement, Amway Global will sell the Company's Inherent Health™ brand of genetic tests through its e-commerce Web site via a hyperlink to the Company's e-commerce site. Amway Global will receive a commission equal to a percentage of net sales received by the Company from Amway Global customers. The Agreement has an initial term of 12 months and is automatically renewable for successive 12-month terms. The Agreement may be terminated by either party upon 120 days written notice.

A copy of the Company's press release, dated October 29, 2009, announcing the Company's entry into the Agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibit.

99.1 Press Release dated October 29, 2009.

---